Maven Securities’s West Pharmaceutical WST Stock Holding History

Maven Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,100	Closed	-$413K	–	1235
2023 Q3	$413K	Buy	+1,100	New	+$425K	﹤0.01%	871

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maven Securities's WST Position: Q4 2019 in Review

Maven Securities sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 14,553 shares — an estimated $2.05M sold.

Maven Securities first reported a position in WST in Q3 2019 and held it in 1 quarter. The position peaked at $2.05M in Q3 2019. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

Maven Securities reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
Maven Securities sold 14,553 West Pharmaceutical shares in Q4 2019, an estimated $2.05M.
Maven Securities first reported a position in West Pharmaceutical in Q3 2019 and held it in 1 quarter.
Maven Securities's West Pharmaceutical position peaked at $2.05M in Q3 2019.
445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.